Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,198 | 25,043 | -97,217 | -76,298 | -50,647 |
| Depreciation Amortization | 613 | 311 | 1,530 | 1,174 | 782 |
| Accounts payable and accrued liabilities | 41,979 | -970 | 6,896 | 5,815 | 6,661 |
| Other Working Capital | 34,065 | -3,775 | 9,076 | 12,958 | 15,178 |
| Other Operating Activity | -145,223 | -39,736 | -2,310 | -3,358 | -5,153 |
| Operating Cash Flow | $-37,368 | $-19,127 | $-82,025 | $-59,709 | $-33,179 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | N/A | -414 | -373 | -351 |
| Investing Cash Flow | $-29 | $N/A | $-414 | $-373 | $-351 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 123,552 | 22,160 | 2,560 | N/A | 953 |
| Other Financing Activity | 0 | 0 | 0 | 1,417 | 0 |
| Financing Cash Flow | $123,552 | $22,160 | $2,560 | $1,417 | $953 |
| Beginning Cash Position | 121,136 | 121,136 | 201,015 | 201,015 | 201,015 |
| End Cash Position | 207,291 | 124,169 | 121,136 | 142,350 | 168,438 |
| Net Cash Flow | $86,155 | $3,033 | $-79,879 | $-58,665 | $-32,577 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,368 | -19,127 | -82,025 | -59,709 | -33,179 |
| Capital Expenditure | -29 | N/A | -414 | -373 | -351 |
| Free Cash Flow | -37,397 | -19,127 | -82,439 | -60,082 | -33,530 |